CEP20: A Potential Drug Target and Biomarker for the LISH Domain-Containing Protein FOPNL
CEP20: A Potential Drug Target and Biomarker for the LISH Domain-Containing Protein FOPNL
The long non-coding RNA (lncRNA) landscape has experienced a surge in the recent years, with the identification of numerous functional lncRNAs that play critical roles in various biological processes. One of these lncRNAs is the long non-coding protein FOPNL (f OPEN NuLIPOProtein-like), which is a member of the LISH (long non-coding RNA-protein interaction) domain family. FOPNL is primarily expressed in the liver and has been implicated in the regulation of various cellular processes, including cell adhesion, migration, and signaling pathways. Although a growing body of research has focused on understanding the functions of FOPNL, its precise role in these processes and its potential as a drug target or biomarker remains poorly understood.
In this article, we will provide an overview of FOPNL, its functions, and the potential implications for drug targeting and biomarker development. We will discuss the current research on FOPNL and its potential therapeutic targets, as well as the current state of FOPNL-based biomarkers and their potential utility in diagnostic applications.
FOPNL: Structure and Function
FOPNL is a member of the LISH domain family, which is characterized by the presence of a conserved domain that includes a nucleotide-binding oligomerization (NBO) domain, a zinc finger, and a hydrophobic domain. FOPNL contains 291 amino acid residues and has a calculated molecular mass of 31.1 kDa. FOPNL is predominantly expressed in the liver, with a highest expression level observed in the left kidney.
The functions of FOPNL are not well understood, but its role in various cellular processes is emerging. FOPNL has been shown to be involved in the regulation of cell adhesion, migration, and signaling pathways. For example, FOPNL has been shown to be a critical regulator of tight junction formation, which is a critical process in the regulation of cell-cell communication. Additionally, FOPNL has been implicated in the regulation of mitochondrial function and energy metabolism.
Despite its involvement in various cellular processes, the precise function of FOPNL remains poorly understood. While several studies have attempted to clarify its role, more research is needed to fully understand its functions and potential as a drug target or biomarker.
Potential Therapeutic Targets
FOPNL has the potential to serve as a drug target due to its unique structure and the various functions it is involved in. Several studies have identified potential therapeutic targets for FOPNL, including the PI3K/Akt signaling pathway, which is a critical pathway involved in cell signaling and whose dysregulation has been implicated in various diseases, including cancer.
Additionally, FOPNL has been shown to be involved in the regulation of cell adhesion, which is a critical process in the regulation of cell behavior and has been implicated in various diseases, including cancer. Therefore, targeting FOPNL may provide new insights into the regulation of cell adhesion and the development of cancer therapies.
Biomarkers
FOPNL has the potential to serve as a biomarker for various diseases, including cancer. The regulation of cell adhesion is a critical process that is often disrupted in cancer, and targeting FOPNL may provide new insights into the mechanisms of cancer progression. Additionally, FOPNL has been shown to be involved in the regulation of mitochondrial function and energy metabolism, which are critical processes that are often disrupted in cancer. Therefore, measuring the levels of FOPNL may provide a valuable diagnostic tool for the early detection of cancer.
Conclusion
In conclusion, FOPNL is a long non-coding protein that is expressed in the liver and has been implicated in various cellular processes. While its precise role in these processes is not well understood, its potential as a drug target or biomarker is significant. The regulation of cell
Protein Name: Centrosomal Protein 20
Functions: Involved in the biogenesis of cilia (PubMed:20551181). Required for the recruitment of PLK1 to centrosomes and S phase progression (PubMed:24018379)
More Common Targets
CEP250 | CEP290 | CEP295 | CEP295NL | CEP350 | CEP350-FGFR1OP-MAPRE1 complex | CEP41 | CEP43 | CEP44 | CEP55 | CEP57 | CEP57L1 | CEP63 | CEP68 | CEP70 | CEP72 | CEP72-DT | CEP76 | CEP78 | CEP83 | CEP83-DT | CEP85 | CEP85L | CEP89 | CEP95 | CEP97 | CEPT1 | CER1 | Ceramidase | Ceramide synthase | CERCAM | CERK | CERKL | CERNA2 | CERS1 | CERS2 | CERS3 | CERS3-AS1 | CERS4 | CERS5 | CERS6 | CERS6-AS1 | CERT1 | CES1 | CES1P1 | CES1P2 | CES2 | CES3 | CES4A | CES5A | CETN1 | CETN2 | CETN3 | CETN4P | CETP | CFAP100 | CFAP100-DT | CFAP107 | CFAP119 | CFAP126 | CFAP141 | CFAP157 | CFAP161 | CFAP20 | CFAP206 | CFAP20DC | CFAP20DC-AS1 | CFAP20DC-DT | CFAP210 | CFAP221 | CFAP251 | CFAP276 | CFAP298 | CFAP299 | CFAP300 | CFAP36 | CFAP410 | CFAP418 | CFAP418-AS1 | CFAP43 | CFAP44 | CFAP44-AS1 | CFAP45 | CFAP46 | CFAP47 | CFAP52 | CFAP53 | CFAP54 | CFAP57 | CFAP58 | CFAP61 | CFAP65 | CFAP68 | CFAP69 | CFAP70 | CFAP73 | CFAP74 | CFAP77 | CFAP90 | CFAP91